Type‐I HTLV antibody in urban and rural Ghana, West Africa
Robert J. Biggar(National Institutes of Health), William A. Blattner(Unknown), Francis Nkrumah(University of Cape Coast), Jeffrey W. Clark(Massachusetts General Hospital), Charlotte Gardiner(National Institutes of Health), Paul H. Levine(National Cancer Institute), William E. Collins(National Institutes of Health), Carl Saxinger(National Institutes of Health)
Cited by 75
Related Papers
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2010|4.5k
Crizotinib in <i>ROS1</i>-Rearranged Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2014|2k
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
|Nature Medicine|2004|2k
<i>ROS1</i> Rearrangements Define a Unique Molecular Class of Lung Cancers
|Journal of Clinical Oncology|2012|1.6k